Table: begin end state 1 6 cytoplasmic 7 28 transmembrane 29 33 non-cytoplasmic 34 59 transmembrane 60 84 cytoplasmic 85 111 transmembrane 112 116 non-cytoplasmic 117 138 transmembrane 139 149 cytoplasmic 150 172 transmembrane 173 193 non-cytoplasmic 194 216 transmembrane 217 231 cytoplasmic 232 254 transmembrane 255 280 non-cytoplasmic 281 302 transmembrane 303 324 cytoplasmic 325 344 transmembrane 345 349 non-cytoplasmic 350 370 transmembrane 371 389 cytoplasmic 390 409 transmembrane 410 414 non-cytoplasmic 415 436 transmembrane 437 482 cytoplasmic
Input: >WP_012102377.1 NCBI__GCF_000016505.1:WP_012102377.1 MEKKHKGLSVLQLTMMALGTIIGGSFFLGSSVAIHALGPFIIISYVLGGILVYFILSALS EMTVADPSPGSFFTFTRKAFGSRAGFTVGWVYWTGMVLAMSSEAAAVSILIRRWFPGISI SFLGSIIIIIITLLNLLGADKLSKLESGLAAVKLLAVVSFIIMALLLITGLLRLNTGAVD VKGVKLSFLLPGGIKSIAGSMLTVMFAYAGFEIIGLAASETDNPKETIPRAIKYTVLSLV ILYIASIYAVLLLIPTDILGENVSPMVAALNRWGMNWTGNVINIVMVIAILSTMLAAMFG IGRMIRSLADEAYAPRWLKDNTNIPYKGMAFSGAAMFLGLMLGLLFPRVYLFLVSCGGFS LLFTYVMIVASQIRMRKNHVYVIEKKQYSYISWITVISLIVIILSMPFIPGQASGLIAGI IIIAFYSAAYTIMKYYIKIKKHGELKDKFNAKERKTGFLMELSKEFIERRKVFKRDKKKY DK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server